Work

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211)

Year: 2004

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Care

DOI: 10.2337/diacare.27.6.1335

Authors: Sten Madsbad, Ole Schmitz, Jonas Ranstam, Grethe Jakobsen, David R. Matthews, on behalf of the NN2211-1310 International Study Group

Institutions: University of Copenhagen, Hvidovre Hospital, Aarhus University Hospital, Novo Nordisk (Denmark), University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk

OpenAlex ID: W1977119153

FWCI: 18.39

Cites: 33

Cited by: 308

Related to: 8